539 results on '"Badve, Sunil V"'
Search Results
2. Systematic Review of the Effects of Iron on Cardiovascular, Kidney and Safety Outcomes in Patients With Chronic Kidney Disease
3. Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
4. Kidney Function, Albuminuria, and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis
5. A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
6. Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data
7. Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial
8. The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset
9. The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial
10. Vitamin D Therapy in Adults With CKD: A Systematic Review and Meta-analysis
11. Participant Perceptions in a Long-term Clinical Trial of Autosomal Dominant Polycystic Kidney Disease
12. Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada
13. Oral Anticoagulant Use in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Review of the Evidence With Recommendations for Australian Clinical Practice
14. Vitamin D status and intermediate vascular and bone outcomes in chronic kidney disease: a secondary post hoc analysis of IMPROVE‐CKD.
15. Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis
16. Relationship Between Dietary Phosphate Intake and Biomarkers of Bone and Mineral Metabolism in Australian Adults With Chronic Kidney Disease
17. A Systematic Review and Meta-Analysis on Effects of Bicarbonate Therapy on Kidney Outcomes
18. Dietary Phosphate Consumption in Australians With Stages 3b and 4 Chronic Kidney Disease
19. Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD
20. Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS
21. Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
22. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease.
23. Risk of Relapse of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids.
24. Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants
25. Effects of iron on cardiovascular, kidney and safety outcomes in patients with chronic kidney disease: a systematic review and meta-analysis
26. The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program
27. Vitamin D therapy in chronic kidney disease: a critical appraisal of clinical trial evidence.
28. Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study
29. Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry
30. Optimizing Clinical Outcomes Beyond Heart Failure With Intravenous Iron.
31. Normalizing serum phosphate based on association, not causation? Lessons in dialysis should have taught us not to fix what we can’t prove is broken
32. The outcomes of patients with kidney failure due to focal segmental glomerulosclerosis (FSGS) in Australia and New Zealand: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)
33. The prevalence of chronic kidney disease in Australian primary care: analysis of a national general practice dataset
34. Kidney Function, Albuminuria and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis
35. The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis
36. The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial
37. Long-term outcomes of end-stage kidney disease for patients with lupus nephritis
38. Recent evidence for direct oral anticoagulants in chronic kidney disease
39. A comparison of arteriovenous fistula failure between Malaysian and Australian and New Zealand participants enrolled in the FAVOURED trial.
40. SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review
41. A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial
42. sj-docx-1-cjk-10.1177_20543581231169610 – Supplemental material for Development and Validation of a Predictive Risk Algorithm for Bleeding in Individuals on Long-term Hemodialysis: An International Prospective Cohort Study (BLEED-HD)
43. Development and Validation of a Predictive Risk Algorithm for Bleeding in Individuals on Long-term Hemodialysis: An International Prospective Cohort Study (BLEED-HD)
44. Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial
45. Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network
46. Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond?
47. Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study
48. The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients
49. Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease
50. Daily Variation in Death in Patients Treated by Long-term Dialysis: Comparison of In-Center Hemodialysis to Peritoneal and Home Hemodialysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.